Skip to content
Monaliben Patel, M.D.

Monaliben Patel, M.D.

she/her/hers

Cancer

UR Medicine Faculty The University of Rochester Medical Faculty Group (URMFG) consists of over 900 specialist and primary care providers spanning 19 departments. URMFG is certified by the National Committee for Quality Assurance.
Accountable Health Partner Accountable Health Partners (AHP) is a network of over 2,000 community and UR medical faculty and a dozen leading hospitals throughout the region. AHP offers a full range of care.
Accepting New Patients

Contact

Call Center (585) 276-3000

About Me

Faculty Appointments

Interim Associate Professor - Department of Medicine, Hematology/Oncology (SMD)

Credentials

Residency & Fellowship

Fellowship, Hematology & Oncology, Cooper University Hospital. 2013 - 2016

Residency, Internal Medicine, Cooper University Hospital. 2010 - 2013

Education

MD | American University of the Caribbean. 2009

Publications

Journal Articles

Health Data Sharing Perspectives of Patients Receiving Care in CancerLinQ-Participating Oncology Practices.

Jagsi R, Suresh K, Krenz CD, Jones RD, Griffith KA, Perry L, Hawley ST, Zikmund-Fisher B, Spector-Bagdady K, Platt J, De Vries R, Bradbury AR, Bansal P, Kaime M, Patel M, Schilsky RL, Miller RS, Spence R

JCO oncology practice.. 2023 August 19 (8):626-636. Epub 05/23/2023.

Disparities in Biomarker Testing and Clinical Trial Enrollment Among Patients With Lung, Breast, or Colorectal Cancers in the United States.

Bruno DS, Hess LM, Li X, Su EW, Patel M

JCO precision oncology.. 2022 June 6 :e2100427. Epub 1900 01 01.

Adding Base-Excision Repair Inhibitor TRC102 to Standard Pemetrexed-Platinum-Radiation in Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer: Results of a Phase I Trial.

Biswas T, Dowlati A, Kunos CA, Pink JJ, Oleinick NL, Malik S, Fu P, Cao S, Bruno DS, Bajor DL, Patel M, Gerson SL, Machtay M

Clinical cancer research : an official journal of the American Association for Cancer Research.. 2022 February 1528 (4):646-652. Epub 1900 01 01.

Impact of p16 Status and Anatomical Site in Anti-PD-1 Immunotherapy-Treated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Patients.

Clancy K, Hamill CS, O'Neill WQ, Vu B, Thuener J, Gui S, Li S, Fowler N, Rezaee R, Lavertu P, Wasman J, Patel M, Shaikh H, Vick E, Madabhushi A, Wise-Draper TM, Burkitt K, Teknos TN, Pan Q

Cancers.. 2021 September 2813 (19)Epub 09/28/2021.

Investigative Landscape in Advanced Non-Melanoma Skin Cancers.

Reddy P, Yao M, Patel M

Current treatment options in oncology.. 2021 June 722 (7):56. Epub 06/07/2021.

The changing landscape of stage III lung cancer: a literature review.

Patel M, Bruno D, Grubb W, Biswas T

Expert review of anticancer therapy.. 2020 August 20 (8):675-686. Epub 08/01/2020.

Acquired amegakaryocytic thrombocytopenia in a patient with occupational chemical exposure.

Patel M, Kalra A, Surapaneni R, Schwarting R, Devereux L

American journal of therapeutics.. 2014 21 (1):e17-20. Epub 1900 01 01.

Loss of plasma membrane integrity, complement response and formation of reactive oxygen species during early myocardial ischemia/reperfusion.

Charlagorla P, Liu J, Patel M, Rushbrook JI, Zhang M

Molecular immunology.. 2013 December 56 (4):507-12. Epub 08/01/2013.

Ofatumumab in rituximab-refractory autoimmune hemolytic anemia associated with chronic lymphocytic leukemia: a case report and review of literature.

Nader K, Patel M, Ferber A

Clinical lymphoma, myeloma & leukemia.. 2013 August 13 (4):511-3. Epub 05/29/2013.